Hospice News October 2, 2024
Palliative care providers face a host of legal and regulatory challenges when seeking to expand patients’ access to certain controlled substances. Providing therapeutic- and medically-guided patient experiences involves a deep understanding of compliance with evolving laws and safe utilization.
Drugs that fall into the realm of federally controlled substances include cannabis, ketamine, MDMA and psychedelics such as psilocybin and LSD, among others.
Much legal, ethical and logistical consideration goes into whether these drugs can be utilized for medicinal and symptom relief purposes, according to Kelsey Hanley-Kollar, senior project manager at Allay Consulting. The consulting company provides guidance around compliance with cannabis and psychedelic product utilization rules. Quality, efficacy and accessibility are additional factors in what is often viewed as a...
Today's Sponsors
Today's Sponsor